Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of NeuroVirology
Published in: Journal of NeuroVirology 2/2009

01-03-2009

Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment

Authors: Giovanni Schifitto, Jianhui Zhong, David Gill, Derick R. Peterson, Michelle D. Gaugh, Tong Zhu, Madalina Tivarus, Kim Cruttenden, Sanjay B. Maggirwar, Howard E. Gendelman, Stephen Dewhurst, Harris A. Gelbard

Published in: Journal of NeuroVirology | Issue 2/2009

Login to get access
Metadata
Title
Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment
Authors
Giovanni Schifitto
Jianhui Zhong
David Gill
Derick R. Peterson
Michelle D. Gaugh
Tong Zhu
Madalina Tivarus
Kim Cruttenden
Sanjay B. Maggirwar
Howard E. Gendelman
Stephen Dewhurst
Harris A. Gelbard
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Journal of NeuroVirology / Issue 2/2009
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI
https://doi.org/10.1080/13550280902758973

Other articles of this Issue 2/2009

Journal of NeuroVirology 2/2009 Go to the issue

OriginalPaper

White matter tract injury and cognitive impairment in human immunodeficiency virusinfected individuals

OriginalPaper

Bovine herpesvirus 5 induces an overproduction of nitric oxide in the brain of rabbits that correlates with virus dissemination and precedes the development of neurological signs

OriginalPaper

Increased frequency of α-synuclein in the substantia nigra in human immunodeficiency virus infection

OriginalPaper

Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways

OriginalPaper

The cellular transcription factor, CCAAT enhancer—binding protein alpha (C/EBP-α), has the potential to activate the bovine herpesvirus 1 immediate-early transcription unit 1 promoter

Erratum

Erratum to: Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages